Phase 3Over the past half dozen-years or so, Brad has indicated from time-to-time that ONC is in discussion(s) with a major, or a number of majors. Be that as it may, I have suspected for some time now that ONC is in talks for two primary reasons. The first being to appear to be genuinely interested in partnering, possible to keep the majors at bay while searching for a suitable White Knight that is both able and willing to rescue the company in the event of a hostile takeover, and secondly to allow time for this small company to complete one phase three success and possibly registration before it acquires a distributer as well as adequte manufacturing facilities capable of supplying the quantities of Reolysin required to complete trials and eventually the release of the product to the market. That could provide funds for present and future trails.
I also wonder what Brad and company are thinking at this time, with Texas and Ohio stepping up to bat. Are these and other US university research centres both capable and willing to run phase three trials? Pehaps as a joint venture? If they are, does Brad need a partner, perhaps just a distributer would do. I can visualize the excitement generating within vareous University scientific communiities as these and other US Universities dream of banner headlines proclaiming that the University of Texas, Ohio, etc. has discovered a viable treatment for many cancers and possibly a cure for some. Think of the prestige, the grants, the funding, and possibly the Nobel Laureate, or is that spoken for?
Just musing, and before you ask, I do have life, thank you
Tumbleweed